SoylentNews
SoylentNews is people
https://soylentnews.org/

Title    Patent Dispute over Nanopore Sequencing Reaches Settlement
Date    Tuesday August 23 2016, @05:53PM
Author    janrinok
Topic   
from the patents-are-power dept.
https://soylentnews.org/article.pl?sid=16/08/23/1334234

An Anonymous Coward writes:

Illumina Inc. and Oxford Nanopore Technologies have reached a settlement in this legal battle, according to a U.S. International Trade Commission document released last week. Oxford has agreed not to import or sell any product containing a pore with an amino acid sequence at least 68% similar to Mycobacterium smegmatis porin (Msp)—the protein at the heart of Illumina's infringement claim—and to destroy any inventory of such products.

[...] Illumina, Inc.—which dominates the genetic sequencing industry—sued Oxford Nanopore Technologies, the first company to market a commercial nanopore platform. Illumina claims that Oxford's two flagship devices infringe on patents that Illumina controls.

[...] Illumina, meanwhile, has yet to release a nanopore platform

[...] Illumina's chance of winning the case might come down to a "very messy" aspect of patent law called the doctrine of equivalents, he says. The doctrine holds that a party can be liable for infringement even if their product doesn't literally match what's described in a patent, provided their product performs the same function, in the same way, to achieve the same result as the patented invention.

https://en.m.wikipedia.org/wiki/Doctrine_of_equivalents
https://www.sciencemag.org/news/2016/03/gene-sequencing-technology-sparks-patent-fight-shrouded-mystery


Original Submission

Links

  1. "Original Submission" - https://soylentnews.org/submit.pl?op=viewsub&subid=15451

© Copyright 2024 - SoylentNews, All Rights Reserved

printed from SoylentNews, Patent Dispute over Nanopore Sequencing Reaches Settlement on 2024-03-29 07:19:02